Literature DB >> 12498024

Draft WHO guidelines on the use of vaccines and antivirals during influenza pandemics.

.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12498024

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  6 in total

1.  Development of solitary chemosensory cells in the distal lung after severe influenza injury.

Authors:  Chetan K Rane; Sergio R Jackson; Christopher F Pastore; Gan Zhao; Aaron I Weiner; Neil N Patel; De'Broski R Herbert; Noam A Cohen; Andrew E Vaughan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-25       Impact factor: 5.464

2.  Immunogenicity and protective efficacy of recombinant M2e.Hsp70c (Hsp70(359-610)) fusion protein against influenza virus infection in mice.

Authors:  Hamidreza Attaran; Hassan Nili; Majid Tebianian
Journal:  Virol Sin       Date:  2014-08-18       Impact factor: 4.327

Review 3.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

4.  Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions.

Authors:  Hans P Duerr; Stefan O Brockmann; Isolde Piechotowski; Markus Schwehm; Martin Eichner
Journal:  BMC Infect Dis       Date:  2007-07-13       Impact factor: 3.090

5.  Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08.

Authors:  Siri H Hauge; Hege S Blix; Katrine Borgen; Olav Hungnes; Susanne G Dudman; Preben Aavitsland
Journal:  Virol J       Date:  2009-05-12       Impact factor: 4.099

6.  Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review.

Authors:  Masja Straetemans; Udo Buchholz; Sabine Reiter; Walter Haas; Gérard Krause
Journal:  BMC Public Health       Date:  2007-09-07       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.